Answers are grounded in this paper and cite their sources.
Despite its growing incidence, hepatocellular carcinoma (HCC) related to metabolic dysfunction-associated steatotic liver disease (MASLD) in non-cirrhotic livers remains poorly characterized. We compared the characteristics, management, survival, and trends of MASLD-related HCC in patients with or without underlying cirrhosis in a large multicenter cohort.
No takes yet. Share an insight, caveat, or question.
Vitellius et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: